Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Novelli

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
JAK-STAT|September 24, 2013
STAT1 and STAT3 in tumorigenesis: A matter of balanceLidia Avalle, Sara Pensa, Gabriella Regis, et al.
Seminars in Cell & Developmental Biology|July 16, 2008
Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signallingGabriella Regis, Sara Pensa, Daniela Boselli, et al.
Molecules (Basel, Switzerland)|April 3, 2021
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic CancerClaudia Curcio, Silvia Brugiapaglia, Sara Bulfamante, et al.
Oncoimmunology|July 29, 2016
Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell responsePaola Cappello, Elisabetta Tonoli, Roberta Curto, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The dark side of immunotherapy: pancreatic cancerGianluca Mucciolo, Cecilia Roux, Alessandro Scagliotti, et al.
Cancers|February 22, 2018
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo PartnersPaola Cappello, Claudia Curcio, Giorgia Mandili, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
IL17A Depletion Affects the Metabolism of Macrophages Treated with GemcitabineCecilia Roux, Gianluca Mucciolo, Joanna Kopecka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
Retroviral-mediated gene transfer restores IL-12 and IL-23 signaling pathways in T cells from IL-12 receptor beta1-deficient patientsMarita Bosticardo, Iren Witte, Claire Fieschi, et al.
Blood|December 7, 2006
In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growthLaura Conti, Gabriella Regis, Angela Longo, et al.
Frontiers in Physiology|November 4, 2016
Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling PathwaysRafael Barreto, Giorgia Mandili, Frank A Witzmann, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
JAK-STAT|September 24, 2013
STAT1 and STAT3 in tumorigenesis: A matter of balanceLidia Avalle, Sara Pensa, Gabriella Regis, et al.
Seminars in Cell & Developmental Biology|July 16, 2008
Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signallingGabriella Regis, Sara Pensa, Daniela Boselli, et al.
Molecules (Basel, Switzerland)|April 3, 2021
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic CancerClaudia Curcio, Silvia Brugiapaglia, Sara Bulfamante, et al.
Oncoimmunology|July 29, 2016
Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell responsePaola Cappello, Elisabetta Tonoli, Roberta Curto, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The dark side of immunotherapy: pancreatic cancerGianluca Mucciolo, Cecilia Roux, Alessandro Scagliotti, et al.
Cancers|February 22, 2018
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo PartnersPaola Cappello, Claudia Curcio, Giorgia Mandili, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
IL17A Depletion Affects the Metabolism of Macrophages Treated with GemcitabineCecilia Roux, Gianluca Mucciolo, Joanna Kopecka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
Retroviral-mediated gene transfer restores IL-12 and IL-23 signaling pathways in T cells from IL-12 receptor beta1-deficient patientsMarita Bosticardo, Iren Witte, Claire Fieschi, et al.
Blood|December 7, 2006
In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growthLaura Conti, Gabriella Regis, Angela Longo, et al.
Frontiers in Physiology|November 4, 2016
Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling PathwaysRafael Barreto, Giorgia Mandili, Frank A Witzmann, et al.
Pageof 11